| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 7 |
| NetGPI | no | yes: 0, no: 7 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 7 |
| GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A4HAV9
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 108 | 110 | PF00675 | 0.444 |
| CLV_NRD_NRD_1 | 118 | 120 | PF00675 | 0.446 |
| CLV_PCSK_KEX2_1 | 108 | 110 | PF00082 | 0.446 |
| CLV_PCSK_KEX2_1 | 118 | 120 | PF00082 | 0.448 |
| CLV_PCSK_PC7_1 | 114 | 120 | PF00082 | 0.380 |
| DOC_MAPK_gen_1 | 49 | 59 | PF00069 | 0.267 |
| DOC_USP7_MATH_1 | 117 | 121 | PF00917 | 0.581 |
| DOC_USP7_MATH_1 | 34 | 38 | PF00917 | 0.478 |
| LIG_14-3-3_CanoR_1 | 81 | 90 | PF00244 | 0.543 |
| LIG_BRCT_BRCA1_1 | 22 | 26 | PF00533 | 0.323 |
| LIG_BRCT_MDC1_1 | 134 | 138 | PF00533 | 0.562 |
| LIG_FHA_2 | 64 | 70 | PF00498 | 0.470 |
| LIG_FHA_2 | 71 | 77 | PF00498 | 0.609 |
| LIG_LIR_Nem_3 | 130 | 136 | PF02991 | 0.570 |
| LIG_SH2_CRK | 133 | 137 | PF00017 | 0.563 |
| LIG_SH2_GRB2like | 13 | 16 | PF00017 | 0.323 |
| LIG_SH2_SRC | 13 | 16 | PF00017 | 0.340 |
| LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.713 |
| LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.349 |
| LIG_SH2_STAT5 | 24 | 27 | PF00017 | 0.362 |
| LIG_SH2_STAT5 | 58 | 61 | PF00017 | 0.268 |
| LIG_SUMO_SIM_anti_2 | 101 | 107 | PF11976 | 0.531 |
| LIG_TYR_ITIM | 56 | 61 | PF00017 | 0.268 |
| MOD_CK2_1 | 70 | 76 | PF00069 | 0.591 |
| MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.426 |
| MOD_GSK3_1 | 20 | 27 | PF00069 | 0.239 |
| MOD_GSK3_1 | 77 | 84 | PF00069 | 0.572 |
| MOD_NEK2_1 | 70 | 75 | PF00069 | 0.513 |
| MOD_PIKK_1 | 81 | 87 | PF00454 | 0.540 |
| MOD_PKA_2 | 117 | 123 | PF00069 | 0.682 |
| MOD_PKB_1 | 75 | 83 | PF00069 | 0.635 |
| MOD_Plk_4 | 34 | 40 | PF00069 | 0.421 |
| TRG_DiLeu_BaEn_1 | 101 | 106 | PF01217 | 0.530 |
| TRG_ENDOCYTIC_2 | 133 | 136 | PF00928 | 0.568 |
| TRG_ENDOCYTIC_2 | 58 | 61 | PF00928 | 0.268 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N1PEA3 | Leptomonas seymouri | 59% | 100% |
| A0A3Q8IFM2 | Leishmania donovani | 79% | 100% |
| A0A422P096 | Trypanosoma rangeli | 36% | 88% |
| A4IA19 | Leishmania infantum | 80% | 100% |
| E9B534 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
| Q4Q2V2 | Leishmania major | 77% | 100% |